Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Intelligent Bio Solutions Inc. Common Stock (INBS)
Intelligent Bio Solutions Inc. Common Stock
XNAS:INBS
19.55
36.62%

Ask
$19.50 - 54.00
Bid
$18.50 - 17.00
Low
$15.5
High
$19
Open
$15.5
Prev Close
$14.31
52W High
27.5
52W Low
4.03
Volume
1718807
Avg Vol (3m)
13682292.8
Float
949918.48
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 3841
Sector: Health Services
Industry: Medical/Nursing Services
Date Listed: 12/23/2020
Primary Exchange: XNAS

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Phone: 646-790-5756
Address: 135 W 41st St,
Address 2: Floor 5
City: New York
State: NY
Postal Code: 10036
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
55
P/E (TTM)
-10.490000
P/B (TTM)
45.024000
Round Lot
100
Composit FIGI
BBG004TP0VX9
Share Class FIGI
BBG004TP0VY8
Share Class Shares Outstanding
9.08M
Weighted Shares Outstanding
9.08M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own INBS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.